The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England

Opeoluwa Fariyike; Nicholas A. Johnson; Birgitta van Bodegraven; Kate Quirke; Zoe C. Venables; James Powell

doi:10.1093/bjd/ljaf135

The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England

Opeoluwa Fariyike
, Nicholas A. Johnson
, Birgitta van Bodegraven
, Kate Quirke
, Zoe C. Venables
, James Powell

Research output: Contribution to journal › Article › peer-review

4 Downloads (Pure)

Original language	English
Pages (from-to)	555–556
Number of pages	2
Journal	British Journal of Dermatology
Volume	193
Issue number	3
Early online date	15 Apr 2025
DOIs	https://doi.org/10.1093/bjd/ljaf135
Publication status	Published - Sept 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/bjd/ljaf135Licence: CC BY

BCC Review Article 06.04.2025 no track changesAccepted author manuscript, 163 KBLicence: CC BY

Cite this

Fariyike, O., Johnson, N. A., van Bodegraven, B., Quirke, K., Venables, Z. C., & Powell, J. (2025). The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England. British Journal of Dermatology, 193(3), 555–556. https://doi.org/10.1093/bjd/ljaf135

Fariyike, Opeoluwa ; Johnson, Nicholas A. ; van Bodegraven, Birgitta et al. / The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England : one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England. In: British Journal of Dermatology. 2025 ; Vol. 193, No. 3. pp. 555–556.

@article{bb76f136f62b4d5f99b397de70f93c30,

title = "The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England",

author = "Opeoluwa Fariyike and Johnson, \{Nicholas A.\} and \{van Bodegraven\}, Birgitta and Kate Quirke and Venables, \{Zoe C.\} and James Powell",

note = "Data availability: Get Data Out Skin data are publicly available from the NDRS data hub (https://digital.nhs.uk/ndrs/data/data-outputs/cancer-data-hub/get-data-out). Raw data can be accessed through data request with the NHS England's Data Access Request Service (DARS).",

year = "2025",

month = sep,

doi = "10.1093/bjd/ljaf135",

language = "English",

volume = "193",

pages = "555{\textendash}556",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley",

number = "3",

}

Fariyike, O, Johnson, NA, van Bodegraven, B, Quirke, K, Venables, ZC & Powell, J 2025, 'The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England', British Journal of Dermatology, vol. 193, no. 3, pp. 555–556. https://doi.org/10.1093/bjd/ljaf135

The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England. / Fariyike, Opeoluwa; Johnson, Nicholas A.; van Bodegraven, Birgitta et al.
In: British Journal of Dermatology, Vol. 193, No. 3, 09.2025, p. 555–556.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England

T2 - one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England

AU - Fariyike, Opeoluwa

AU - Johnson, Nicholas A.

AU - van Bodegraven, Birgitta

AU - Quirke, Kate

AU - Venables, Zoe C.

AU - Powell, James

N1 - Data availability: Get Data Out Skin data are publicly available from the NDRS data hub (https://digital.nhs.uk/ndrs/data/data-outputs/cancer-data-hub/get-data-out). Raw data can be accessed through data request with the NHS England's Data Access Request Service (DARS).

PY - 2025/9

Y1 - 2025/9

UR - https://www.scopus.com/pages/publications/105013632258

U2 - 10.1093/bjd/ljaf135

DO - 10.1093/bjd/ljaf135

M3 - Article

SN - 0007-0963

VL - 193

SP - 555

EP - 556

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -

Fariyike O, Johnson NA, van Bodegraven B, Quirke K, Venables ZC, Powell J. The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England. British Journal of Dermatology. 2025 Sept;193(3):555–556. Epub 2025 Apr 15. doi: 10.1093/bjd/ljaf135

The role of limited life expectancy in personalised treatment decisions: 1 in 6 patients aged 80+ with a basal cell carcinoma die within 2 years of diagnosis in England: one in six patients aged 80+ years with a basal cell carcinoma die within 2 years of diagnosis in England

UN SDGs

Access to Document

Other files and links

Cite this